Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Stereotaxis, Inc.
In an interview with Medtech Insight, Stereotaxis CEO David Fischel explained how the company intends to continue its recovery after a troubled near decade of decline.
Mickelsen, an electrophysiologist at the University of Iowa, recently joined the rapidly growing San Diego-area company as Chief Translational Science Officer and is helping to guide the company’s development of novel electrophysiology therapies to treat cardiac arrhythmias.
The IPO is expected to raise $166m to support R&D of new arrhythmia mapping and ablation technologies and expand commercial operations.
Acutus Medical Inks Marketing Deal With Biotronik, Mapping Its Way To Electrophysiologists Outside US
Biotronik will help Acutus to bring its cardiac mapping software and guidance system to electrophysiologists worldwide.
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Surgical Equipment & Devices